• Home
  • Conference Program

Conference Program


The preliminary program for the 2022 Clinical Cytometry Meeting & Course is posted below. Please check back for updates. All program times are listed in Eastern Time.

COURSE DATES
Friday, October 21 - Sunday, October 23

MEETING DATES
Sunday, October 23 - Tuesday, October 25


  Fri - Oct 21      Sat - Oct 22      Sun - Oct 23      Mon - Oct 24      Tue - Oct 25   


Sunday, October 23rd

8:00 - 12:00 PM
Course
COURSE SUNDAY AM
Ballroom West

8:00
Technical Tips for CD4 Counts
Jolene Cardinali.

8:45
Primary Immunodeficiencies
Michelle Paessler.

9:45
Mid-Morning Break
.

10:00
Plasma Cell Neoplasms
Qi Gao.

10:55
T/NK Cell Lymphomas
Min Shi.

11:55
Course Wrap Up
Andrea Marcogliese.
12:00 - 2:00 PM
Corporate Workshop
CORPORATE LUNCH AND LEARN
Chair/Organizer: Sa Wang
3rd Floor - Drummond East Centre

The Corporate Lunch & Learn sessions will be held on Sunday, October 23 from 12:00 PM - 2:00 PM and offer an opportunity for you to hear about the latest products from the participating companies. There is no charge to attend. The first 100 attendees to arrive by 12:10 PM, will receive a complimentary boxed lunch, while supplies last.

12:00 PM - BECKMAN COULTER
12:30 PM - BD BIOSCIENCES
1:00 PM - CYTEK BIOSCIENCES
1:30 PM - SLINGSHOT BIOSCIENCES

2:15 - 2:30 PM
Plenary Session
MEETING WELCOME
Chair/Organizer: Adam Seegmiller
Ballroom West

Welcome
Adam Seegmiller.
2:30 - 5:00 PM
Plenary Session
PLENARY SESSION 1: THE FLOW LAB OF THE FUTURE.TODAY? ROBOTS? AI? (MORE) LASERS?
Chair/Organizer: Jean Oak, David Ng
Ballroom West

2:30
Automated Specimen Processing: Two lab's experience - part 1
Leo Lin.

2:50
Automated Specimen Processing: Two lab's experience - part 2
Ahmad Al-Attar.

3:10
Spectral Flow Cytometry in the Clinical Arena
Megan McClausland.

3:45
Coffee Break
.

4:05
Brief Introduction to Clinical AI
David Ng.

4:20
Automated Analysis in the Clinical Flow Lab
Wolfgang Kern.
5:00 - 5:40 PM
Keynote
WALLACE H COULTER LECTURE
Ballroom West

WALLACE H. COULTER LECTURE
Andrea Illingworth.
5:45 - 7:15 PM
Poster Session
POSTER SESSION & EXHIBIT RECEPTION
Ballroom Central/East

100
Developing and Validating a SARS-CoV-2 serology multiplex assay
Thomas S Alexander, Kathleen Schroeder, Patrick Romano, Julie Bick, Michael McGrane, Jaqueline Davis, Renold Capocasale. FlowMetric Diagnostics, Doylestown, PA, USA

101
Development of an Efficient and Cost-Effective Flow Cytometry Testing Strategy for Body Fluids.
Erin Alston1, Sam Sadigh1, 2, Steven Sotirakos1, Daniel Dees1, Olga Pozdnyakova1, 2. 1Brigham and Women's Hospital, Boston, MA, USA.2Harvard Medical School, Boston, MA, USA

102
CellMek SPS Instrument Performance: Percent gated populations from automated versus manual sample preparations using a wash/stain/lyse & fix/wash workflow with a 10-color antibody panel in liquid or dry format
Kelly Andrews, Gang Xu, Xizi Dai, Karen Lo, Jessica Ashbaugh, Jin Zhang, Ernesto Staroswiecki. Research and Development, Beckman Coulter Life Sciences, Miami, FL, USA

103
Peripheral Blood Flow Cytometry Utilization: Are We Choosing Wisely?
Davsheen Bedi1, 2, Shikha Malhotra1, 2, Michael Linden3, Nidhi Aggarwal1, 2, Sara Monaghan1, 2. 1UPMC, Pittsburgh, PA, USA.2University of Pittsburgh Medical School, Pittsburgh, PA, USA.3University of Minnesota, Minneapolis, MN, USA

104
T lymphoblastic lymphoma with preserved immunophenotypic properties of cortical thymocytes and restricted cytoplasmic TRBC1 expression
Holly Berg1, Pedro Horna2, Jonathon Gralewski2. 1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA, .2Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

105
Angioimmunoblastic T-cell lymphoma (AITL), monotypic by TRBC1 testing, in association with CD10-positve large B-cell lymphoma detected by Flow Cytomtery.
Seble Chekol. CSI Laboratories

106
ElevatedSerum cytokinesmay predict the aGVHDoccuranceand survivalof B-ALLpatients treated withCD19-CAR-Tbridging allogeneic hematopoietic stem cell transplantation
Man Chen1, Minjing Fu1, Aixian Wang2, Meiwei Gong2, Wei Zhao1, Hui Wang2. 1Beijing Lu Daopei Hospital, Beijing, China.2Hebei Yanda Lu Daopei Hospital, Langfang, China

107
Retroperitoneal soft tissue biopsy in a clinical setting of acquired immunodeficiency (HIV infection)
George Deeb. Emory University, Department of pathology and laboratory medicine

108
Flow Cytometry Immunophenotypic Features of Pure Erythroid Leukemia and the Distinction from Reactive Erythroid Precursors
Hong Fang, Sa A. Wang, M. James You, Shimin Hu, Roberto N. Miranda, Zhenya Tang, Pei Lin, Jeffrey L. Jorgensen, Jie Xu, Beenu Thakral, Ellen J. Schlette, Siba El Hussein, Carlos E. Bueso-Ramos, L Jeffrey Medeiros, Wei Wang. The University of Texas MD Anderson Cancer Center, Houston, TX, USA

109
A 12-Colour-Adapted Single-Tube Approach for Lymphoma Screening+Diagnosis
Marie Guthrie1, Graeme Quest1, 2. 1Kingston Health Sciences Centre, Kingston, ON, Canada.2Queen's University, Kingston, ON, Canada

110
Immunomagnetic isolation of PBMCs from Cyto-Chex BCT-stabilized whole blood
Jessica M. Hart, Rebecca A. Wilshusen. Streck, La Vista, NE, USA

111
Use of Increased Testing Volume to Justify Need for Additional Staffing in Flow Cytometry
Nicholas Haslett1, 2, Lisa Reste1, Juli-Anne Gardner1, 2, Katherine Devitt1, 2. 11Department of Pathology & Laboratory Medicine, University of Vermont Medical Center, Burlington, VT, USA.2Larner College of Medicine at the University of Vermont, Burlington, VT, USA

112
Validation of a Novel and Comprehensive Assay for B Lymphoblastic Leukemia Residual Disease Detection by Flow Cytometry.
Ruba Irani1, Brent Holmes1, Maurice O'Gorman1, 2, Ntasha Roy1, Alexandra Kovach1, 3, Brent L Wood1, 3. 1Department of Pathology and Laboratory Medicine, Childrens Hospital Los Angeles, Los Angeles, CA, USA.2Department of Pediatrics, Keck School of Medicine, USC, Los Angeles, CA, USA.3Department of Pathology, Keck School of Medicine, USC, Los Angeles, CA, USA

113
A novel chunk-for-pooling machine learning model to detect measurable residual disease (MRD) in acute myeloid leukemia (AML) with flow cytometric data
Yun-Chun Lin1, 2, Jeng-Lin Li3, Teng-Jen Chang1, 2, Yu-Chun Huang1, 2, Yu-Fen Wang1, 2, Chi-Chun Lee1, 2, 3, Paul K. Wallace4, Bor-Sheng Ko1, 2, 5, 6. 1AHEAD Medicine Corporation, Berkeley, CA, USA.2AHEAD Intelligence Ltd, Taipei, Taiwan.3Department of Electrical Engineering, National Tsing Hua University, Hsin Chu, Taiwan.4Department of Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.5Department of Hematological Oncology. National Taiwan University Cancer Center, Taipei, Taiwan.6Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

114
A 2 Laser 13-color cFluor B Cell Monitoring Panel for Analyzing B cell Subsets in Anti-CD20 Treated Autoimmune Patients
Heather/E Miller, Kevin Tran, Mark Edinger, Jingyi Chen , Jun Deng. Cytek Biosciences, Inc, Fremont, CA, USA

115
CSF Flow Cytometry for Hematopoietic Malignancies: Two-years Experience from Roswell Park Cancer Center
Nouran Momen1, 2, Joseph Tario1, Kai Fu1, You-Wen Qian1. 1Roswell Park Cancer Center, Buffalo, NY, USA.2 Cairo University, Cairo, Egypt

116
Quality control metrics for CD34 stem cell enumeration assay on the BD FACS Lyric flow cytometer
Evangelos Ntrivalas, Sylvie Wiener-Fedus, Viktor Moroz, Matthew Thomsen, Peter Maslak. Cellular Immunology, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

117
Establishing NK-cell clonality by flow cytometry from a large cohort of normal donors and NK-cell neoplasms
Gregory otteson, Michael Timm, Pedro Horna, Dragan Jevremovic, William Morice, Horatiu Olteanu, Jansen Sehault, Min Shi. Mayo Clinic, Rochester, MN, USA

118
Characterizing Genotype-Phenotype Relationships in Acute Myeloid Leukemia through High-Dimensional Data Analysis
Kevin E Shopsowitz1, Jack Lofroth1, Xiu Q Wang1, Makhan Rana2, Geoffrey Chan2, Monika Hudoba De Badyn1, 2, Nadia Medvedev1, 2, Xuehai Wang1, 2. 1Department of Pathology and Laboratory Medicine University of British Columbia, Vancouver, BC, Canada.2Division of Hematopathology Vancouver General Hospital, Vancouver, BC, Canada

119
Diagnostic pitfall, an unusual case of NK/T cell lymphoproliferative disorder with aberrant expression of CD20 and kappa light chain
Tanja Skierka, Nashwa Abed, Liqun Yin. Incyte Diagnostics, Spokane Valley, WA, USA

120
Experience with the BD FACSDuetTM Sample Preparation System in a High-Volume Reference Laboratory
Miguel Francoise S. Ventura1, John Andreasen1, Leo Lin1, 2, Julio C. Delgado1, 2. 1ARUP Laboratories, Salt Lake City, UT, USA.2University of Utah, Salt Lake City, UT, USA

121
The Immunophenotypic Profile of DiGeorge Syndrome Using Artificial Intelligence Assisted Flow Cytometry Analysis
Tyler Yeager1, Alan Wang2, Sophia Wang1, Mayu Morita1, Guang Fan1. 1Oregon Health and Science University, Portland, OR, USA.2DeepCyto, West Lynn, OR, USA

122
CD34+ Cell Analysis on the BD FACSLyricand BD FACSCalibur Flow Cytometers Using UK NEQAS CD34+ Stem Cell Enumeration (SCE) Program Samples and the BD SCE Kit
Yang Zeng, Angela Chen, Farzad Oreizy, Harshada Rohamare , Michelle McNamara. BD Biosciences, San Jose, CA, USA

123
A single-tube-20-color-21-antigen flow cytometric assay in the diagnosis and measurable residual disease monitoring of T-cell lymphoblastic leukemia
Jing-Ping Zhang, Qi Gao, Xiaotian Sun, Jennifer Goshaw, Mikhail Roshal. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
7:15 - 8:15 PM
Social Event
WOMEN OF ICCS
Ballroom West

Leading from Within
Debra Leonard.